Cargando…
Gene therapy of the central nervous system : from bench to bedside /
Few areas of biomedical research provide greater opportunities for radically new therapies for devastating diseases that have evaded treatment so far than gene therapy. This is particularly true for the brain and nervous system, where gene transfer has become a key technology for basic research and...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Boston :
Academic Press,
2006.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn162129568 | ||
| 003 | OCoLC | ||
| 005 | 20231117014802.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 070802s2006 ne a ob 001 0 eng d | ||
| 040 | |a OPELS |b eng |e pn |c OPELS |d OPELS |d OCLCQ |d CDX |d N$T |d YDXCP |d OCLCE |d E7B |d EBLCP |d BTCTA |d MHW |d IDEBK |d OCLCQ |d GBVCP |d CHVBK |d OCLCQ |d DEBSZ |d OCLCQ |d D6H |d OCLCA |d LEAUB |d OL$ |d NLW |d OCLCQ |d OCLCA |d INARC |d OCLCQ |d OCLCO |d COM |d OCLCO |d OCLCF |d OCLCQ |d OCLCO | ||
| 015 | |a GBB6H8767 |2 bnb | ||
| 016 | 7 | |a 573155402 |2 DE-101 | |
| 016 | 7 | |a 101266709 |2 DNLM | |
| 019 | |a 74908110 |a 85782405 |a 144219692 |a 232311585 |a 271462260 |a 607704226 |a 609274113 |a 823857182 |a 823927262 |a 824116893 |a 824168671 |a 1086547713 |a 1118387349 |a 1193944184 | ||
| 020 | |a 9780123976321 | ||
| 020 | |a 0123976324 | ||
| 020 | |a 0080454372 |q (electronic bk.) | ||
| 020 | |a 9780080454375 |q (electronic bk.) | ||
| 020 | |a 1280637927 | ||
| 020 | |a 9781280637926 | ||
| 035 | |a (OCoLC)162129568 |z (OCoLC)74908110 |z (OCoLC)85782405 |z (OCoLC)144219692 |z (OCoLC)232311585 |z (OCoLC)271462260 |z (OCoLC)607704226 |z (OCoLC)609274113 |z (OCoLC)823857182 |z (OCoLC)823927262 |z (OCoLC)824116893 |z (OCoLC)824168671 |z (OCoLC)1086547713 |z (OCoLC)1118387349 |z (OCoLC)1193944184 | ||
| 042 | |a dlr | ||
| 050 | 4 | |a RC350.G45 |b G46 2006 | |
| 060 | 4 | |a WL 300 | |
| 072 | 7 | |a HEA |x 039110 |2 bisacsh | |
| 072 | 7 | |a MED |x 056000 |2 bisacsh | |
| 072 | 7 | |a MJN |2 bicssc | |
| 082 | 0 | 4 | |a 616.8/046 |2 22 |
| 245 | 0 | 0 | |a Gene therapy of the central nervous system : |b from bench to bedside / |c [edited by] Michael G. Kaplitt and Matthew J. During. |
| 260 | |a Amsterdam ; |a Boston : |b Academic Press, |c 2006. | ||
| 300 | |a 1 online resource (xiv, 355 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a Few areas of biomedical research provide greater opportunities for radically new therapies for devastating diseases that have evaded treatment so far than gene therapy. This is particularly true for the brain and nervous system, where gene transfer has become a key technology for basic research and has recently been translated to human therapy in several landmark clinical trials. Gene Therapy of the Central Nervous System: From Bench to Bedside represents the first definitive volume on this subject. Edited by two pioneers of neurological gene therapy, this volume contains contributions by leaders who helped create this field and are expanding the promise of gene therapy for the future of basic and clinical neuroscience. Drawing upon this extensive collective experience, this book provides clear and informative reviews on a variety of subjects of interest to anyone exploring or using gene therapy for neurobiological applications in research and clinical praxis. * Presents gene transfer technologies with particular emphases upon novel vehicles, immunological issues and the role of gene therapy in stem cells * Discusses preclinical areas that are likely to translate into clinical studies in the near future, including epilepsy, pain and amyotrophic lateral sclerosis * Includes "insider" information on technological and regulatory issues which can often limit effective translation of even the most promising idea into clinical use. | ||
| 505 | 0 | |a SECTION I. GENE TRANSFER TECHNOLOGY AND REGULATORY ISSUES -- 1. Design and optimization of expression cassettes including promoter choice and regulatory lements -- 2. Identification of Novel AAV Serotypes for Use as Vectors -- 3. HSV amplicon vectors for gene delivery to the nervous system -- 4. Influence of the immune system on CNS gene transfer -- 5. Targeted induction of endogenous neural stem and progenitor cells: A new strategy for gene therapy of neurological disease -- 6. Neurosurgical Targeting, Delivery and Infusion of Gene Therapy Agents in the Brain -- 7. Gene Transfer for Neurological Disease: Agencies, Policies and Process -- SECTION II. GENE THERAPY FOR DEGENERATIVE AND FUNCTIONAL DISORDERS -- 8. Gene therapy for Parkinsons disease -- 9. Non human primate models for testing gene therapy for neurodegenerative disorders -- 10. Delivery of Molecular Therapeutics into the CNS and their Distribution within the Brain -- 11. Gene therapy for CNS diseases using intrabodies -- 12. Gene therapy for epilepsy -- SECTION IIII. PSYCHIATRIC AND BEHAVIORAL GENE THERAPY -- 13. Genetic manipulation of learning and memory -- 14. Psychiatric applications of viral vectors -- 15. Use of viral vectors to influencebehavior -- SECTION IV. GENE THERAPY FOR PAIN AND SPINAL CORD DISEASES -- 16. Herpes simplex vector mediated gene transfer to the peripheralnervous system for the treatment of polyneuropathy and chronic pain -- 17. Characterization of pain receptors in the spinal cord using a viral vector for spatial-temportal gene targeting -- 18. Viral vector mediated gene therapy of pain -- 19. VEGF, an angiogenic factor with neurotrophic activity, useful for treatment of ALS? -- 20. Viral Vector Axonal Uptake and Retrograde Transport: Mechanisms and Applications -- 21. Gene therapy for spinal cord injury -- V. GENE THERAPY FOR BRAIN TUMORS AND NEUROGENETIC DISEASES -- 22. Prodrug-Activation Gene Therapy -- 23. Clinical trials of gene therapy for Canavan Disease -- 24. Gene therapy for the late infantile form of Batten disease -- 25. Molecular Imaging of Gene Therapy for Neurogenetic Diseases. | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 506 | 1 | |a Legal Deposit; |c Only available on premises controlled by the deposit library and to one user at any one time; |e The Legal Deposit Libraries (Non-Print Works) Regulations (UK). |5 WlAbNL | |
| 540 | |a Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force. |5 WlAbNL | ||
| 650 | 0 | |a Nervous system |x Diseases |x Gene therapy. | |
| 650 | 0 | |a Gene therapy. | |
| 650 | 2 | |a Central Nervous System Diseases |x therapy |0 (DNLM)D002493Q000628 | |
| 650 | 2 | |a Genetic Therapy |0 (DNLM)D015316 | |
| 650 | 6 | |a Syst�eme nerveux |0 (CaQQLa)201-0007359 |x Maladies |0 (CaQQLa)201-0007359 |x Th�erapie g�enique. |0 (CaQQLa)201-0380879 | |
| 650 | 6 | |a Th�erapie g�enique. |0 (CaQQLa)201-0193146 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Nervous System (incl. Brain) |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Neurology. |2 bisacsh | |
| 650 | 7 | |a Gene therapy |2 fast |0 (OCoLC)fst00939638 | |
| 700 | 1 | |a Kaplitt, Michael G. | |
| 700 | 1 | |a During, Matthew J. | |
| 776 | 0 | 8 | |i Print version: |t Gene therapy of the central nervous system. |d Amsterdam ; Boston : Academic Press, 2006 |z 0123976324 |z 9780123976321 |w (OCoLC)65360708 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780123976321 |z Texto completo |